Publication | Open Access

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

Autoimmune DiseaseImmunosuppressive TherapyImmunologyGastroenterologyClinical TrialsClinical GastroenterologyCombination TherapyUlcerative ColitisMedicineConcomitant Immunosuppressant Therapy